Tailoring Fiber Diameter in Electrospun Poly(ɛ-Caprolactone) Scaffolds for Optimal Cellular Infiltration in Cardiovascular Tissue Engineering
- 1 February 2009
- journal article
- Published by Mary Ann Liebert Inc in Tissue Engineering, Part A
- Vol. 15 (2) , 437-444
- https://doi.org/10.1089/ten.tea.2007.0294
Abstract
Despite the attractive features of nanofibrous scaffolds for cell attachment in tissue-engineering (TE) applications, impeded cell ingrowth has been reported in electrospun scaffolds. Previous findings have shown that the scaffold can function as a sieve, keeping cells on the scaffold surface, and that cell migration into the scaffold does not occur in time. Because fiber diameter is directly related to the pore size of an electrospun scaffold, the objective of this study was to systematically evaluate how cell delivery can be optimized by tailoring the fiber diameter of electrospun poly(epsilon-caprolactone) (PCL) scaffolds. Five groups of electrospun PCL scaffolds with increasing average fiber diameters (3.4-12.1 microm) were seeded with human venous myofibroblasts. Cell distribution was analyzed after 3 days of culture. Cell penetration increased proportionally with increasing fiber diameter. Unobstructed delivery of cells was observed exclusively in the scaffold with the largest fiber diameter (12.1 microm). This scaffold was subsequently evaluated in a 4-week TE experiment and compared with a poly(glycolic acid)-poly(4-hydroxybutyrate) scaffold, a standard scaffold used successfully in cardiovascular tissue engineering applications. The PCL constructs showed homogeneous tissue formation and sufficient matrix deposition. In conclusion, fiber diameter is a crucial parameter to allow for homogeneous cell delivery in electrospun scaffolds. The optimal electrospun scaffold geometry, however, is not generic and should be adjusted to cell size.Keywords
This publication has 31 references indexed in Scilit:
- Esophageal epithelium regeneration on fibronectin grafted poly(l-lactide-co-caprolactone) (PLLC) nanofiber scaffoldBiomaterials, 2007
- Autologous Human Tissue-Engineered Heart ValvesCirculation, 2006
- Fabrication and characterization of six electrospun poly(α-hydroxy ester)-based fibrous scaffolds for tissue engineering applicationsActa Biomaterialia, 2006
- Tissue Engineering of Human Heart Valve Leaflets: A Novel Bioreactor for a Strain-Based Conditioning ApproachAnnals of Biomedical Engineering, 2005
- Statistical geometry of pores and statistics of porous nanofibrous assembliesJournal of The Royal Society Interface, 2005
- Electrospinning of nanofibersJournal of Applied Polymer Science, 2005
- Fibrin as a cell carrier in cardiovascular tissue engineering applicationsBiomaterials, 2004
- Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiationJournal of Biomedical Materials Research Part A, 2003
- Optimal Cell Source for Cardiovascular Tissue Engineering: Venous vs. Aortic Human MyofibroblastsThe Thoracic and Cardiovascular Surgeon, 2001
- Cell size of alveolar macrophages: an interspecies comparison.Environmental Health Perspectives, 1997